Statistics for Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic Escalation
Total visits
| views | |
|---|---|
| Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic Escalation | 62 |
Total visits per month
| views | |
|---|---|
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
File Visits
| views | |
|---|---|
| H11430.pdf(legacy) | 72 |
| H11430.pdf | 2 |
| QUESTIONÁRIO 1º CICLO.pdf(legacy) | 1 |
Top country views
| views | |
|---|---|
| United States | 33 |
| Portugal | 25 |
| Canada | 1 |
| Germany | 1 |
| Singapore | 1 |
| Ukraine | 1 |